Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$47,087,226
-$13,398,688 QoQ
Shares Held
39,258
-40.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
4.09%
of 13F equity value
Holder Rank
#567
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2023CallValue
$13,633,774
CallShares
39,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $87,605,755 across 4 Drug Manufacturers - General names. LLY ranks #1 (53.7% of the industry book) .
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,087,226 | 39,258 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $60,485,914 | 65,762 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $73,388,829 | 68,289 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $171,781,057 | 225,139 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $208,931,969 | 268,023 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $226,115,987 | 273,778 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $230,552,396 | 298,643 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $264,579,779 | 298,643 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $270,385,399 | 298,643 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $232,332,308 | 298,643 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $174,084,977 | 298,643 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $160,410,114 | 298,643 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $140,057,594 | 298,643 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $102,559,979 | 298,643 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $13,633,774 | 39,700 | Call | Defined | 2023-05-15 | |
| 2022-12-31 | $109,255,555 | 298,643 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $96,566,214 | 298,643 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $96,829,019 | 298,643 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $85,522,395 | 298,643 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $82,491,169 | 298,643 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $121,406,377 | 525,455 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $120,602,431 | 525,455 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $98,165,503 | 525,455 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $59,202,901 | 350,645 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||